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Abstract
Background: HIV prevalence in Puerto Rico is nearly twice that of the mainland United States, a level that was
substantially fueled by injection drug use. Puerto Rico has a longstanding history of health provision by the public
sector that directly affects how HIV and substance use disorder (SUD) treatment services are provided and funded.
As part of pre-implementation research for a randomized trial of a community-level intervention to enhance HIV
care access for substance users in San Juan, Puerto Rico, we sought to understand the structural and health policy
environment for providing HIV and SUD treatments.
Methods: We conducted semi-structured qualitative interviews (n = 8) with government and program
administrators in English and Spanish. Data were analyzed to identify dominant and recurrent themes.
Results: Participants discussed how lack of integration among medical and mental health service providers, lack of
public transportation, and turnover in appointed government officials were barriers to integrated HIV and SUD
treatment. Federal funding for support services for HIV patients was a facilitator. The Affordable Care Act has limited
impact in Puerto Rico because provisions related to health insurance reform do not apply to U.S. territories.
Discussion and Conclusions: Implications for intervention design include the need to provide care coordination for
services from multiple providers, who are often physically separated and working in different reimbursement systems,
and the potential for mobile and patient transportation services to bridge these gaps. Continuous interaction with
political leaders is needed to maintain current facilitators. These findings are relevant as the current economic crisis in
Puerto Rico affects funding, and may be relevant for other settings with substance use-driven epidemics.
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Background
HIV prevalence in Puerto Rico is nearly twice that of the
mainland United States [1, 2] with injection drug use
playing a large role in transmission [1–3]. Studies of in-
jection drug users (IDUs) in Puerto Rico have found a
higher frequency of drug use, needle sharing, reduced
time to HIV sero-conversion, and greater AIDS-related
mortality compared to the U.S. [4, 5].
Puerto Rico has a history of publicly funded healthcare
beginning in 1960 when the Puerto Rico government as-
sumed responsibility for the provision of health care ser-
vices, and began offering universal coverage to residents
[6, 7]. However, publicly-funded services became associ-
ated with the medically indigent creating a two-tiered
system based on ability to pay [8]. Puerto Rico subse-
quently introduced La Reforma (Health Reform) in 1994,
resulting in the privatization of public health facilities
and contracting with managed care organizations
(MCOs). Research on La Reforma has been unable to
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demonstrate an improvement to access or quality of
mental health services [6, 7].
La Reforma was overhauled and rebranded in 2010 as
Mi Salud with the goals of integrating physical and be-
havioral health care and improving access to quality care
[8]. Most notably, Mi Salud contracted the delivery of
mental health services, including most SUD services, to
APS Healthcare Puerto Rico (APS-PR) [9]. Mi Salud is
financed by federal Medicaid allocations to Puerto Rico
and Puerto Rico government funds. Future Puerto Rico
government funding is uncertain as the local economy
and the government’s financial condition worsen [10]. In
2015, Puerto Rico also received $47 million in Ryan
White funds and $38.5 million from SAMHSA to fi-
nance its care of HIV-infected patients and substance
users [11, 12]. Faith-based organizations also play an im-
portant role in providing services for substance users in
Puerto Rico [13, 14]. These organizations generally pro-
vide residential abstinence-only programs with durations
as long as 20 months, often located outside of urban
centers.
In this article, we explore the structural and health
policy environment for providing HIV and SUD treat-
ment services in Puerto Rico. We interviewed key infor-
mants representing government and program
administrators involved with the allocation and provision
of these services in the second half of 2013. Our object-
ive was to describe structural and health policy factors
that act as barriers and facilitators of integrated HIV and
SUD treatment. We sought to inform hypotheses about
how interventions can effectively improve outcomes for
HIV-infected substance users and stem the spread of
HIV in Puerto Rico and in similar environments with
limited resources. Findings are part of the pre-
implementation research of a randomized trial of a
community-level structural intervention to enhance ac-
cess to HIV care for substance users in San Juan, Puerto
Rico (NCT01792752).
Methods
Study setting, participants, and data collection
Participants (n = 8) were identified by our clinical trial
collaborators in Puerto Rico as the most relevant stake-
holders at the time and included: key federal and local
government administrators (n = 3), HIV and/or SUD
treatment program administrators (n = 4), and a non-
governmental organization administrator (n = 1) whose
programs were active in the San Juan, PR metro area.
The semi-structured interview guide (see Additional
file 1) asked about: IDUs and the local HIV epidemic,
needs of IDUs, attitudes toward substance use and
HIV, mobilization and community engagement, health
insurance, and public policy and the political environ-
ment. Interviews were conducted by two of the
authors (DH and BRS), one of whom is bilingual
(DH). One interview was conducted in English, one
in Spanish, and the remainder in a mix of English
and Spanish.
Interviews were audio recorded and transcribed by a
third-party service and appear in the language(s) in
which they were conducted. We analyzed interview data
for dominant and recurrent themes. Two bilingual au-
thors not involved in the interviews (JAL and PAT)
coded the transcripts using an iterative process [15]. Re-
sults were reviewed and agreed upon by all members of
the study team. Analyses were conducted in NVivo 10
(QSR International, Doncaster, Burlington, MA).
Ethics approval
This study was reviewed and approved by the Columbia
University Medical Center (AAAK8805), Weill Cornell
Medicine (1302013624), and University of Puerto Rico
(1680213) Institutional Review Boards. Informed consent
was obtained from all participants in line with guidelines
and procedures from these ethics committees.
Results
The most salient themes related to the structural and
health policy environment for HIV and SUD care in
Puerto Rico are presented alongside illustrative quotes.
Themes are presented for each of three topics in the
interview guide (see Additional file 1): Public Policy and
Politics, Health Insurance, and Needs of IDUs.
Public policy and politics
Several interviewees commented on the influential role
of the territory’s Governor in appointing program offi-
cials and that top-to-bottom staff turnover is common
when a new administration takes office. One govern-
ment administrator described political turnover in the
context of the mainland U.S. as follows:
[…] let me use New York as an example. When a new
administration comes in, the new commissioner is
appointed, right, but the deputy commissioner, the
senior staff, the directors of the different programs,
they are all pretty the same. […] In Puerto Rico, it’s
different. When a new administration comes in, the
head of the agency is moved out. The deputy is moved
out, if there is a deputy. The senior staff are moved
out, and the directors of the programs move out.
This cycling of personnel in-and-out of office creates
uncertainty for programs that rely on Puerto Rico gov-
ernment funding and policy making. An HIV treatment
program administrator described the need to educate
government program officials and to be proactive in
order to ensure the continuity of government funding
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and the uncertainty introduced by the constant change
in elected officials.
[With] new administrations, you get new people that
don’t know about HIV. […] So we have to have been
teaching, educating people, our bosses, [telling them]
‘Look, it’s done this way. This is done that way. This is
not done this way.’
Health insurance
All respondents described a lack of integration between
mental, behavioral, and physical health care services in
Puerto Rico, despite the stated objective of Mi Salud, to
improve care integration. One treatment program ad-
ministrator described the situation as:
20 years ago the government decided to implement
access for everybody but… they forget about mental
health. Okay, so through the years, they are trying to
put mental health [back in] but it’s still, it’s physical
health and mental health.
This artificial barrier between physical and mental
health care was frequently cited by program administra-
tors who reported they could not integrate the two be-
cause of the structure of the APS-PR contract with Mi
Salud. Some had tried working with APS-PR to bring
mental health staff onsite, but they often encountered
resistance and financial burdens. One treatment pro-
gram administrator reported success in co-locating ser-
vices, but said implementation was suboptimal:
The psychologist from APS used the facility of this
center. They make the appointments, everything, no
communication between the primary care physician
and anything. That’s not integration of services. That’s
co-location or whatever.
APS-PR allows for the treatment of opioid-
dependence with buprenorphine at a non-APS site, but
providers must first obtain additional certification from
APS. Reimbursement rates at non-APS sites were de-
scribed as insufficient, not covering the cost of the ser-
vice, leading to poor uptake at other sites. A treatment
program administrator described some of the conse-
quences of this divided care delivery system.
We have patients here who are on buprenorphine.
[The APS] psychiatrists don’t know our patients, they
don’t know anything about HIV, so we had difficulty
because a couple of our patients almost died…because
a doctor from APS give [a contraindicated medication]
to a patient on buprenorphine, and the patient came
in and starts having problems.
Interviewees also described the sources of reimburse-
ment for HIV services. Typically, medical services pro-
vided by licensed professionals were described as being
reimbursed using Mi Salud funds or federal primary care
block grant funds, while care coordination or “wrap-
around” services were funded by the federal Ryan White
program. Another treatment program administrator pro-
vided examples on how a community health center pro-
viding HIV services may receive funds:
… I will have my Bureau Primary Health Care 330
grantee dollars [funded by HRSA], so from that pot I
will cover the HIV patients’ primary care services.
Then I will get [Ryan White] Part C, then I will have
the additional support services, some kind of
medication. And then I have a contract with the [Ryan
White] Part B to get for those patients to be able to
access the medications that are not covered under the
government health insurance plan [Mi Salud] in
Puerto Rico that we have not talked about. That is
where most of these patients, especially the drug users
or the homeless, will be covered under, that is the
government health insurance plan.
A government administrator described a situation
where Ryan White funds were used to support the salary
of health psychologists to work with patients on medica-
tion adherence.
Todo paciente, toda persona VIH tiene que recibir un
screening de mental health y substance abuse. Toda,
no importa su situación. Ellos son parte de la clínica,
donde, por ejemplo, ellos van a trabajar con la
adherencia del paciente a tratamiento. Van a estar
pendientes al CD4, a la carga viral. Identificar
cualquier situación que dificulte que el paciente sea
adherente al tratamiento. El, el propósito o el objetivo,
o el foco de su intervención, es asegurar que el
paciente VIH se mantenga adherente al tratamiento.
[All patients, everyone with HIV, must receive a
mental health and substance abuse screening. It
doesn’t matter the situation. They (the clients) are part
of a clinic where, for example, they are going to work
on treatment adherence. They are going to be
monitoring the CD4, viral load, to identify whatever
factor may be making it difficult to adhere to
treatment. The purpose or the objective, or the focus of
the intervention is to make sure HIV patients
maintain adherence to the treatment.]
The use of Ryan White funds for screening and
brief intervention was justified as being related to
HIV treatment (and not solely mental health) and
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avoids making a referral for the patient to an off-site
APS-PR-funded site for these services. However, if
other mental health services or SUD treatment ser-
vices are required, the patient must then go to an
APS-PR provider.
In December 2013, when these interviews were con-
ducted, most interviewees spoke of the Governor’s
last minute decision to use expected ACA funds to
expand Medicaid rather than create a health ex-
change. One treatment program administrator
expressed doubt about the effect of ACA on Medicaid
expansion:
Well, the numbers are around 400,000 are the people
in Puerto Rico that doesn’t have any insurance. And
with the Health Reform [ACA], they supposed to have
the ability to have around 20,000 more people into the
Medicaid program.
This interviewee indicated that a small number of un-
insured individuals would have become eligible for in-
surance under the ACA, and the overwhelming majority
of uninsured Puerto Ricans would remain without health
insurance, based on the funds expected at that time to
be received from ACA. Subsequently, in July 2014 the
U.S. Department of Health and Human Services deter-
mined that ACA provisions related to health insurance
reform do not apply to territories such as Puerto Rico
[16]. As a result, $925 million in federal ACA-related
grant funds to Puerto Rico for Medicaid expansion were
eliminated, although other increases in federal Medicaid
funding for Puerto Rico that began in 2011 remained in
place [17].
Needs of IDUs
Many interviewees also discussed the lack of public
transportation as a barrier to accessing services and de-
scribed transportation as an unmet need. One govern-
ment administrator noted:
Well, Mi Salud does not cover… medical
transportation that they [patients] need to get to their
appointments, to go to the pharmacy to buy a
medication, they don’t have those [services]…
A treatment program administrator recalled a patient
who had travelled a long distance for his mental health
appointment. After securing transportation from a friend
to get to the clinic, he arrived only to find the provider
hadn’t made it to clinic that day.
… and what happened when (he arrived,) they said to
him, ‘Come tomorrow, maybe then,’ (and) he decide,
‘Okay, I won’t go. I won’t go.’
Transportation remains a significant barrier for the
majority of patients due to poor public transportation
infrastructure and alternate arrangements must be
sought from friends/relatives or programs offering this
service.
Discussion and Conclusions
All of the interviewees described significant barriers to
the provision of high-quality integrated care for Puerto
Ricans living with HIV and SUD. While Puerto Rico’s Mi
Salud provides coverage to nearly half of the island’s
population, physical and mental health service delivery
remains siloed and services are rarely co-located leading
to sub-optimal delivery of appropriate services. Lack of
public transportation further limits access, especially be-
cause of the lack of co-located services. Overall, inter-
viewees described a system where the responsibility for
accessing and coordinating physical and mental health
services falls primarily on the patient and the patient’s
support system.
Wrap-around services for HIV-infected patients that
facilitate integrated care funded by the Ryan White Care
Act are available in Puerto Rico, but these services are
vulnerable to overall cuts in Ryan White funding. On-
going education of political leadership in Puerto Rico on
integrated care needs for HIV and SUD is necessary be-
cause of the frequent staff turnover in government agen-
cies. Furthermore, the ACA will have little impact in
Puerto Rico because as a territory it is not eligible to re-
ceive ACA grant funds.
Our findings, which echo results of previous studies
[18, 19], have several implications for the design of inter-
ventions to improve treatment for HIV-infected sub-
stance users in Puerto Rico. First, interventions should
provide care coordination services that assist patients in
accessing care from multiple providers who are not co-
located and work in different care systems. Second, lack
of public transportation is a barrier to care which can be
addressed by providing patient transportation services or
by bringing care services to patients using mobile vans
[20–22]. Third, continuous interaction with political
leaders in Puerto Rico is needed to educate them on the
value of and resources needed to provide integrated HIV
and SUD care.
Our findings illustrate the need for interventions with
substance users in Puerto Rico. Substance use and co-
morbid mental health issues are associated with lower
rates of engagement in care and treatment adherence
[21, 23, 24]. It is now well established that having a de-
tectable HIV viral load is related to higher rates of trans-
missions [25, 26]. Inadequate coordination of care in
areas with substance use-driven HIV epidemics will per-
petuate high rates of HIV incidence.
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This study has several limitations. First, qualitative
data are subject to researcher bias which we sought to
address by having the interviews conducted by re-
searchers with extensive qualitative research experience.
Second, the HIV and SUD treatment providers we inter-
viewed were all located in the San Juan, Puerto Rico
metropolitan area, and the generalizability of their ex-
perience to providers located outside of this area is un-
known. Third, we focused on the structural and health
policy themes that emerged from our analysis, and did
not include content that was more related to clinical
management issues and patient attitudes. Finally, while
some interviewees noted the overall negative impact of
the economic situation in Puerto Rico, and the impact of
municipal budget cuts was discussed, our interviews
were conducted before the most recent financial crisis in
Puerto Rico. These more recent events will likely ad-
versely affect funding and availability of health services
in Puerto Rico and may accelerate the departure of
health professionals from Puerto Rico [27]. These con-
cerns further emphasize the need to continue to educate
local government officials, as well as raising questions
for further study about the effect of the financial crisis
on the demand and capacity for health services in Puerto
Rico, and whether or not greater integration of services
has the potential to create savings for the health care
system as funding is reduced.
Communities in the U.S. with limited resources and
substance use-driven epidemics face similar barriers,
particularly rural areas with increased IDU among
young adults at high risk for HIV and HCV infections
[28–31]. Many of these communities are also facing
weak economic environments and may be in states
that have decided not to use ACA funds to expand
Medicaid coverage. Interventions developed and
tested in Puerto Rico could potentially be adapted to
these communities. However, Puerto Rico faces some
unique challenges due to the current design of the
Mi Salud health system. These challenges will be ad-
dressed in planned future implementation research to
investigate the budgetary impact and sustainability in
Puerto Rico of the interventions that are being tested
in the ongoing clinical trial.
Additional file
Additional file 1: The open-ended interview guide used during data
collection is available as a supplemental file entitled Interview
Guide_Community Members_v1.0_ENG.doc. (DOC 54 kb)
Abbreviations
ACA: Patient Protection and Affordable Care Act; APS-PR: APS Healthcare
Puerto Rico; IDU: Injection drug user; MCO: Managed care organization;
PR: Puerto Rico; SUD: Substance use disorder
Acknowledgements
The authors gratefully acknowledge the respondents for their participation in
the interviews and the following individuals for comments and assistance in
the preparation of the manuscript: Norma Delgado, PhD, Greduvel Durán,
MD, Ashley A. Eggman, MS, and Melissa Marzán-Rodríguez, DrPH.
Funding
This research was supported by the National Institute on Drug Abuse
(R01DA035280, P30DA040500) and the National Institute of Allergy and
Infectious Diseases (P30AI073961). The content of this article is solely the
responsibility of the authors and does not necessarily represent the official
views of the funding agencies or the U.S. government.
Availability of data and materials
Data are not available for online access, however readers who wish to gain
access to the data can write to the corresponding author Jared A. Leff, MS at
jal2033@med.cornell.edu with their requests. Access can be granted subject
to the Institutional Review Board (IRB) and the research collaborative
agreement guidelines as required by our institution and funder.
Authors’ contributions
JAL and PAT conducted the analysis and drafted the manuscript. DH and
BRS collected data and contributed to the analysis. All authors contributed
to the editing and approval of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was reviewed and approved by the Columbia University Medical
Center (AAAK8805), Weill Cornell Medicine (1302013624), and University of
Puerto Rico (1680213) Institutional Review Boards. Informed consent was
obtained verbally from all participants in line with guidelines and procedures
from these ethics committees.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Healthcare Policy & Research, Weill Cornell Medical College,
425 East 61st Street, Suite 301, New York, NY 10065, USA. 2Department of
Sociomedical Sciences, Mailman School of Public Health, Columbia
University, New York, NY, USA. 3Department of Public Health Sciences,
University of Miami Miller School of Medicine, Miami, FL, USA. 4Department
of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
5Department of Medicine, University of Puerto Rico School of Medicine, San
Juan, Puerto Rico, USA. 6Puerto Rico Department of Health, San Juan, Puerto
Rico, USA. 7Iniciativa Comunitaria de Investigación, San Juan, Puerto Rico,
USA.
Received: 9 June 2016 Accepted: 18 March 2017
References
1. Diagnoses of HIV infection and AIDS in the United States and dependent
areas, 2010 [https://www.cdc.gov/hiv/pdf/statistics_surveillance_report_vol_
22.pdf]. Accessed 3 Jan 2017.
2. Diagnoses of HIV Infection in the United States and Dependent Areas, 2013
[https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-
surveillance-report-vol-25.pdf]. Accessed 3 Jan 2017.
3. CDC Prevention. Geographic differences in HIV infection among Hispanics
or Latinos–46 states and Puerto Rico, 2010. MMWR Morb Mortal Wkly Rep.
2012;61(40):805–10.
4. Deren S, Gelpi-Acosta C, Albizu-Garcia CE, Gonzalez A, Des Jarlais DC,
Santiago-Negron S. Addressing the HIV/AIDS epidemic among Puerto Rican
people who inject drugs: the need for a multiregion approach. Am J Public
Health. 2014;104(11):2030–6.
Leff et al. BMC Health Services Research  (2017) 17:232 Page 5 of 6
5. Mino M, Deren S, Colon HM. HIV and drug use in Puerto Rico: findings from
the ARIBBA study. J Int Assoc Phys AIDS Care. 2011;10(4):248–59.
6. Alegria M, McGuire T, Vera M, Canino G, Freeman D, Matias L, Albizu C,
Marin H, Calderon J. The impact of managed care on the use of outpatient
mental health and substance abuse services in Puerto Rico. Inquiry. 2001;
38(4):381–95.
7. Alegria M, McGuire T, Vera M, Canino G, Matias L, Calderon J. Changes in
access to mental health care among the poor and nonpoor: results from the
health care reform in Puerto Rico. Am J Public Health. 2001;91(9):1431–4.
8. Puerto Rico Medicaid Strategy 2013-2016 [http://www.asespr.org/wp-
content/uploads/2015/10/PR-Quality-Strategy-Final-version-_-8-8-2014-CMS-
approved.pdf]. Accessed 20 Mar 2017.
9. The Puerto Rico Health Insurance Administration (ASES) Selects APS
Healthcare to Implement The miSalud Healthcare Program for Mental





111061294.html]. Accessed 3 Jan 2017.
10. Puerto Ricans Brace for Crisis in Health Care [http://www.nytimes.com/2015/
08/03/us/health-providers-brace-for-more-cuts-to-medicare-in-puerto-rico.
html?_r=0]. Accessed 7 June 2016.
11. About the Ryan White HIV/AIDS Program [http://hab.hrsa.gov/abouthab/
aboutprogram.html]. Accessed 7 June 2016.
12. State Summaries FY 2015/2016: Puerto Rico [http://www.samhsa.gov/grants-
awards-by-state/puerto%20rico]. Accessed 7 June 2016.
13. Hansen H. Isla evangelista-a story of church and state: Puerto Rico’s faith-
based initiatives in drug treatment. Cult Med Psychiatry. 2005;29(4):433–56.
14. Hansen H, Alegria M, Caban CA, Pena M, Lai S, Shrout P. Drug treatment,
health, and social service utilization by substance abusing women from a
community-based sample. Med Care. 2004;42(11):1117–24.
15. Streubert HJ, Carpenter DR. Qualitative Research in Nursing. Advancing the
Humanistic Imperative, Second edn. Philadelphia, PA: Lippincot Williams &
Wilkins; 1999.
16. July 16 2014 Memo from Marilyn Tavenner to Commisioner Gregory R.
Francis Clarifying Role of ACA in Territories [http://www.cms.gov/CCIIO/
Resources/Letters/Downloads/letter-to-Francis.pdf]. Accessed 7 June 2016.
17. What do you know about Medicaid in Puerto Rico? [http://www.cis-
partners.com/cis-compliance-blog/what-do-you-know-about-medicaid-in-
puerto-rico/]. Accessed 7 June 2016.
18. Hannold EM, Freytes IM, Uphold CR. Unmet health services needs
experienced by Puerto Rican OEF/OIF veterans and families post
deployment. Mil Med. 2011;176(4):381–8.
19. Simmons VN, Jimenez JC, Castro E, Litvin EB, Gwede CK, Vadaparampil ST,
McLntyre J, Meade CD, Brandon TH, Quinn GP. Initial efforts in community
engagement with health care providers: perceptions of barriers to care for
cancer patients in Puerto Rico. P R Health Sci J. 2011;30(1):28–34.
20. Sagrestano LM, Clay J, Finerman R, Gooch J, Rapino M. Transportation
vulnerability as a barrier to service utilization for HIV-positive individuals.
Aids Care. 2014;26(3):314–9.
21. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell
C, Altice FL, Bangsberg DR, Bartlett JG, et al. Guidelines for improving entry
into and retention in care and antiretroviral adherence for persons with HIV:
evidence-based recommendations from an International Association of
Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.
22. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug
users with HIV infection: a review of barriers and ways forward. Lancet.
2010;376(9738):355–66.
23. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH.
Treatment of medical, psychiatric, and substance-use comorbidities in
people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.
24. Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The
impact of alcohol use and related disorders on the HIV Continuum of care:
a systematic review. Curr HIV/AIDS Rep. 2015;12(4):421–36.
25. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC,
Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al.
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med.
2011;365(6):493–505.
26. Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S,
Zhang Y, Rueda S, McGee F, Peck R, et al. Systematic review of HIV
transmission between heterosexual serodiscordant couples where the HIV-
positive partner is fully suppressed on antiretroviral therapy. PLoS One.
2013;8(2):e55747.
27. As Puerto Rico’s fiscal crisis grows into a humanitarian one, health care
looks like the first big casualty [https://www.washingtonpost.com/news/
wonk/wp/2015/11/05/as-puerto-ricos-fiscal-crisis-grows-into-a-humanitarian-
one-health-care-looks-like-the-first-big-casualty/?utm_term=.8cc9339b87a7].
Accessed 16 Feb 2017.
28. CDC Prevention. Notes from the field:hepatitis C virus infections among
young adults–rural Wisconsin, 2010. MMWR Morb Mortal Wkly Rep. 2012;
61(19):358.
29. Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, Hillman
D, Hon J, Hoover KW, Patel MR, et al. Community outbreak of HIV infection
linked to injection drug use of oxymorphone–Indiana, 2015. MMWR Morb
Mortal Wkly Rep. 2015;64(16):443–4.
30. Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, Hamdounia
SB, Church DR, Barton K, Fisher C, et al. Emerging epidemic of hepatitis C
virus infections among young nonurban persons who inject drugs in the
United States, 2006-2012. Clin Infect Dis. 2014;59(10):1411–9.
31. Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L,
Serrecchia J, Blankenship S, Ward JW, Holtzman D, et al. Increases in
hepatitis C virus infection related to injection drug use among persons
aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-
2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Leff et al. BMC Health Services Research  (2017) 17:232 Page 6 of 6
